Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Atherosclerosis. 2013 Oct 31;232(1):52–58. doi: 10.1016/j.atherosclerosis.2013.10.021

Table 3.

Univariate association of candidate predictors with CIMT.

Wilcoxon p-value N Modeled?
Male gender 0.03 125 Yes
Prevalent cardiovascular disease 0.10 125 No
Hypertension treatment 0.19 125 Yes
Diabetes mellitus 0.41 125 Yes
Framingam risk class 0.007 125 No
Rho p-value N Modeled?
FRS ATPIII 0.31 0.0004 125 Yes
Age 0.31 0.0003 125 Yes
Plasma HIV RNA 0.06 0.51 125 No
CD4+ T cell count −0.04 0.66 125 No
CD8+ T cell activation (% CD38+/HLA-DR+) −0.08 0.38 108 No
CD14+CD16−% or Mono 1 −0.11 0.22 108 No
CD14+CD16++ % or Mono 2 0.03 0.71 108 No
CD14dim/−CD16++% or Mono 3 −0.04 0.62 108 No
CD14dimCD16−% or Mono 4 0.15 0.11 108 Yes
C-RP 0.22 0.01 121 Yes
IL-6 0.17 0.06 121 Yes
IL-8 0.23 0.02 121 Yes
IL-10 0.09 0.31 121 No
IL-1β 0.07 0.41 121 No
TNF 0.13 0.16 121 No
MPO 0.04 0.66 121 No
MMP-9 −0.04 0.68 121 No
tPAI-1 0.02 0.76 121 No
NT ProBNP 0.01 0.86 121 No
sICAM-1 0.01 0.90 121 No
sVCAM-1 0.25 0.006 121 Yes
sE-Selectin 0.12 0.19 121 No
MCP-1 0.12 0.19 121 No
VEGF 0.15 0.10 121 Yes
Soluble CD14 −0.06 0.52 121 No
SAA 0.21 0.02 121 Yes
SAP 0.10 0.25 121 No

Abbreviations: FRS ATPIII, Framingham risk score ATPIII, C-RP = C-reactive protein, IL-6 = Interleukin-6, IL-8 = Interleukin 8, IL-10 = Interleukin-10, IL-1b = Interleukin-1 beta, TNF = tumor necrosis factor, MPO = myeloperoxidase, MMP-9 = matrix metalloproteinase 9, tPAI-1 = tissue plasminogen activator inhibitor-1, NT ProBNP = N-terminal fragment of brain natriuretic peptide, sICAM-1 = soluble intercellular cell adhesion molecule 1, sVCAM-1 = soluble vascular adhesion molecule 1, sE-Selectin = soluble E (CD62E), endothelial-leukocyte adhesion molecule 1, MCP-1 = monocyte chemoattractant protein 1, soluble CD14 = free plasma CD14, SAA = serum amyloid alpha, SAP = serum amyloid P.